Q2 2022 GSK plc Earnings Call Transcript
Hello, everyone. It's Nick as mentioned. Welcome to our first half and Q2 2020 conference call and webcast for investors and analysts. This is our first quarter as a new biopharma company. And earlier today, the presentation was posted to gsk.com. It was also sent by e-mail to our distribution list.
Please turn to Slide 2. This is the usual safe harbor statement, and we'll be making comments on our performance using constant exchange rates, or CR, unless otherwise stated. As a reminder, GSK satisfied the formal criteria according to IFRS 5 for treating Consumer Healthcare as a discontinued operation effective from 30th of June 2022.
The Consumer Healthcare business was demerged on 18th of July to form Haleon. And as a result, we're presenting continuing operations for GSK. Earlier today, Haleon also published a trading update and will be announcing its Q2 results in September.
Please turn to Slide 3. This is today's agenda, where we plan to cover all aspects of our half year and Q2 2020 results. The presentation will last at least 35 minutes with a further 40 minutes for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
